{
    "nct_id": "NCT05046171",
    "official_title": "Decreasing Polypharmacy in Older Adults with Curable Cancers: a Pilot Cluster-randomized Trial",
    "inclusion_criteria": "* Be age â‰¥65 years;\n* Have a diagnosis of malignancy including aggressive lymphoma or cancers of the breast, gastrointestinal system, genitourinary system, or lung;\n* Be initiating chemotherapy, alone or in combination with other systemic antineoplastic agents, (for a period of at least 3 months) within 4 weeks of enrollment;\n* Screen positive for polypharmacy (>10 medications) or potentially inappropriate medications\n* Be able to read and write English;\n* Be able to give informed consent, as determined by the primary oncologist, or has a legally authorized representative to sign consent in the case of cognitive impairment.\nHealthy volunteers allowed\nMust have minimum age of 65 Years",
    "exclusion_criteria": "* Be planned to receive a cancer treatment regimen that does not include standard cytotoxic chemotherapy (e.g., only targeted therapies, hormonal therapies, monoclonal antibody therapies, immunotherapy, etc.),\n* Have surgery or radiation without concurrent chemotherapy planned within 3 months of consent,\n* Have a planned referral to the geriatric oncology clinic (SOCARE) within one month of treatment initiation,\n* Lack decisional capacity, if a legally authorized representative is not available to sign consent and participate in study visits and follow-up phone calls.",
    "miscellaneous_criteria": ""
}